USNA USANA Health Sciences, Inc.

NYSE
$14.71

USANA Health Sciences, Inc. (USNA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Moderately bearish Selling ran elevated versus USNA's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
6
10 transactions
Purchases
$0
0 shares
Sales
$637.0K
33,603 shares
Net activity
-$637.0K
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $637.0K 10 transactions · 33,603 shares

Largest single sale: $129.1K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Neidig Brent CHIEF COMMERCIAL OFFICER Sell 5,002 $19.45 $97.3K None left
Neidig Brent CHIEF COMMERCIAL OFFICER Sell 909 $20.01 $18.2K 5,002 −15.4% of holding
Neidig Brent CHIEF COMMERCIAL OFFICER Sell 1,602 $20.15 $32.3K 5,911 −21.3% of holding
Jones Paul A. CHIEF PEOPLE OFFICER Sell 5,561 $18.50 $102.9K None left
Fleming John Turman Director Sell 2,450 $17.93 $43.9K 4,230 −36.7% of holding
Jones Paul A. CHIEF PEOPLE OFFICER Sell 6,813 $18.95 $129.1K 5,561 −55.1% of holding
IIEKKING G DOUG CHIEF FINANCIAL OFFICER Sell 5,360 $18.75 $100.5K None left
FULLER GILBERT A Director Sell 1,057 $18.66 $19.7K None left
Foukas Joshua CHIEF LEGAL OFFICER Sell 3,791 $19.82 $75.1K None left

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.